1. Abdalgani M, Filipovich AH, Choo S, Zhang K, Gifford C, Villanueva J, Bleesing JJ, Marsh RA. Accuracy of Flow Cytometric Perforin Screening for Detecting Patients with Fhl Due to Prf1 Mutations. Blood. 2015; 126:1858-60.
  2. Abruzzo TA, Geller JI, Kimbrough DA, Michaels S, Correa ZM, Cornell K, Augsburger JJ. Adjunctive Techniques for Optimization of Ocular Hemodynamics in Children Undergoing Ophthalmic Artery Infusion Chemotherapy. J Neurointerv Surg. 2015; 7:770-6.
  3. Adams A, Bolanos L, Dexheimer P, Karns R, Aronow B, Komurov K, Jegga A, Casper K, Patil Y, Wilson K. Irak1 Is a Novel Dek Transcriptional Target and Is Essential for Head and Neck Cancer Cell Survival. Oncotarget. 2015; 6:43395-407.
  4. Adams AK, Bolanos LC, Dexheimer PJ, Karns RA, Aronow BJ, Komurov K, Jegga AG, Casper KA, Patil YJ, Wilson KM, Starczynowski DT, Wells SI. Irak1 Is a Novel Dek Transcriptional Target and Is Essential for Head and Neck Cancer Cell Survival. Oncotarget. 2015; 6:43395-407.
  5. Adams DM, Hammill AM, Mobberley-Schuman PS, Trenor CC, 3rd. Comment On: Steroid-Resistant Kaposiform Hemangioendothelioma: A Retrospective Study of 37 Patients Treated with Vincristine and Long-Term Follow-Up. Pediatr Blood Cancer. 2015; 62:2056.
  6. Adams DM, Trenor CC, 3rd, Hammill AM, Vinks AA, Patel MN, Chaudry G, Wentzel MS, Mobberley-Schuman PS, Campbell LM, Brookbank C, Gupta A, Chute C, Eile J, McKenna J, Merrow AC, Fei L, Hornung L, Seid M, Dasgupta AR, Dickie BH, et al. Efficacy and Safety of Sirolimus in the Treatment of Complicated Vascular Anomalies. Pediatr. 2016; 137:e20153257.
  7. Adams GN, Rosenfeldt L, Frederick M, Miller W, Waltz D, Kombrinck K, McElhinney KE, Flick MJ, Monia BP, Revenko AS, Palumbo JS. Colon Cancer Growth and Dissemination Relies Upon Thrombin, Stromal Par-1, and Fibrinogen. Cancer Res. 2015; 75:4235-43.
  8. Alsaied T, Alsidawi S, Allen CC, Faircloth J, Palumbo JS, Veldtman GR. Strategies for Thromboprophylaxis in Fontan Circulation: A Meta-Analysis. Heart. 2015; 101:1731-7.
  9. Alsaied T, Mohameden M, Lee L, Lawson S, Mantell B, Saqr A, Nagarajan R. Abdominal Pain, Fatigue, and Constipation in a Teenager Female: Is It Worth Further Investigations? Clinc Pediatr (Phila). 2016; 55:986-9.
  10. Amarachintha S, Sertorio M, Wilson A, Li X, Pang Q. Fanconi Anemia Mesenchymal Stromal Cells-Derived Glycerophospholipids Skew Hematopoietic Stem Cell Differentiation through Toll-Like Receptor Signaling. Stem Cells. 2015; 33:3382-96.
  11. Anderson CP, Matthay KK, Perentesis JP, Neglia JP, Bailey HH, Villablanca JG, Groshen S, Hasenauer B, Maris JM, Seeger RC, Reynolds CP. Pilot Study of Intravenous Melphalan Combined with Continuous Infusion L-S,R-Buthionine Sulfoximine for Children with Recurrent Neuroblastoma. Pediatr Blood Cancer. 2015; 62:1739-46.
  12. Anyanwu J, Williams O, Sautter C, Kasirye P, Hume H, Opoka R, Latham T, Ndugwa C, Ware R, John C. Novel Use of Hydroxyurea in an African Region with Malaria: Protocol for a Randomized Controlled Clinical Trial. pmc/PMC4937184. JMIR Research Protocols. 2016; 5:e110.
  13. Arumugam PI, Mullins ES, Shanmukhappa SK, Monia BP, Loberg A, Shaw MA, Rizvi T, Wansapura J, Degen JL, Malik P. Genetic Diminution of Circulating Prothrombin Ameliorates Multiorgan Pathologies in Sickle Cell Disease Mice. Blood. 2015; 126:1844-55.
  14. Ayas M, Eapen M, Le-Rademacher J, Carreras J, Abdel-Azim H, Alter BP, Anderlini P, Battiwalla M, Bierings M, Buchbinder DK, Bonfim C, Camitta BM, Fasth AL, Gale RP, Lee MA, Lund TC, Myers KC, Olsson RF, Page KM, Prestidge TD, et al. Second Allogeneic Hematopoietic Cell Transplantation for Patients with Fanconi Anemia and Bone Marrow Failure. Biol Blood Marrow Transplant. 2015; 21:1790-5.
  15. Ballen K, Ahn K, Chen M, Abdel-Azim H, Ahmed I, Aljurf M, Antin J, Bhatt A, Boeckh M, Chen G. Infection Rates among Acute Leukemia Patients Receiving Alternative Donor Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2016; 22:1636-45.
  16. Barry D, Xu K, Meadows S, Zheng Y, Norden P, Davis G, Cleaver O. Cdc42 Is Required for Cytoskeletal Support of Endothelial Cell Adhesion During Blood Vessel Formation in Mice. Development. 2015; 142:3058.
  17. Benito JM, Godfrey L, Kojima K, Hogdal L, Wunderlich M, Geng HM, Marzo I, Harutyunyan KG, Golfman L, North P, Kerry J, Ballabio E, Ni Chonghaile T, Gonzalo O, Qiu YH, Jeremias I, Debose L, O'Brien E, Ma HL, Zhou P, et al. Mll-Rearranged Acute Lymphoblastic Leukemias Activate Bcl-2 through H3k79 Methylation and Are Sensitive to the Bcl-2-Specific Antagonist Abt-199. Cell Rep. 2015; 13:2715-27.
  18. Bick G, Zhang F, Meetei AR, Andreassen PR. Coordination of the Recruitment of the Fancd2 and Palb2 Fanconi Anemia Proteins by an Ubiquitin Signaling Network. Chromosoma. 2016:1-14.
  19. Bielack SS, Smeland S, Whelan JS, Marina N, Jovic G, Hook JM, Krailo MD, Gebhardt M, Papai Z, Meyer J, Nadel H, Randall RL, Deffenbaugh C, Nagarajan R, Brennan B, Letson GD, Teot LA, Goorin A, Baumhoer D, Kager L, et al. Methotrexate, Doxorubicin, and Cisplatin (Map) Plus Maintenance Pegylated Interferon Alfa-2b Versus Map Alone in Patients with Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative Map: First Results of the Euramos-1 Good Response Randomized Controlled Trial. J Clin Oncol. 2015; 33:2279-87.
  20. Boscolo E, Limaye N, Huang L, Kang KT, Soblet J, Uebelhoer M, Mendola A, Natynki M, Seront E, Dupont S, Hammer J, Legrand C, Brugnara C, Eklund L, Vikkula M, Bischoff J, Boon LM. Rapamycin Improves Tie2-Mutated Venous Malformation in Murine Model and Human Subjects. J Clin Invest. 2015; 125:3491-504.
  21. Breese E, Buechele C, Dawson C, Cleary M, Porteus M. Use of Genome Engineering to Create Patient Specific Mll Translocations in Primary Human Hematopoietic Stem and Progenitor Cells. Plos One. 2015; 10:e0136644.
  22. Bride KL, Vincent T, Smith-Whitley K, Lambert MP, Bleesing JJ, Seif AE, Manno CS, Casper J, Grupp SA, Teachey DT. Sirolimus Is Effective in Relapsed/Refractory Autoimmune Cytopenias: Results of a Prospective Multi-Institutional Trial. Blood. 2016; 127:17-28.
  23. Buechele C, Breese EH, Schneidawind D, Lin CH, Jeong J, Duque-Afonso J, Wong SH, Smith KS, Negrin RS, Porteus M, Cleary ML. Mll Leukemia Induction by Genome Editing of Human Cd34+ Hematopoietic Cells. Blood. 2015; 126:1683-94.
  24. Bukowinski AJ, Burns KC, Parsons K, Perentesis JP, O'Brien MM. Toxicity of Cancer Therapy in Adolescents and Young Adults (Ayas). Semin Oncol Nurs. 2015; 31:216-26.
  25. Burkes SA, Adams DM, Hammill AM, Chute C, Eaton KP, Welge JA, Wickett RR, Visscher MO. Skin Imaging Modalities Quantify Progression and Stage of Infantile Haemangiomas. Br J Dermatol. 2015; 173:838-41.
  26. Burkes SA, Patel M, Adams DM, Hammill AM, Eaton KP, Randall Wickett R, Visscher MO. Infantile Hemangioma Status by Dynamic Infrared Thermography: A Preliminary Study. Int J Dermatol. 2016; 55:e522-32.
  27. Cai X, Gao L, Teng L, Ge J, Oo ZM, Kumar AR, Gilliland DG, Mason PJ, Tan K, Speck NA. Runx1 Deficiency Decreases Ribosome Biogenesis and Confers Stress Resistance to Hematopoietic Stem and Progenitor Cells. Cell Stem Cell. 2015; 17:165-77.
  28. Cajaiba M, Jennings L, Rohan S, Perez-Atayde A, Marino-Enriquez A, Fletcher J, Geller J, Leuer K, Bridge J, Perlman E. Alk-Rearranged Renal Cell Carcinomas in Children. Gene Chromosome Canc. 2016; 55:442-51.
  29. Cajaiba MM, Jennings LJ, Rohan SM, Leuer KM, Anagnost MR, Fahner JB, Fulton BK, Geller JI, Perlman EJ. Expanding the Spectrum of Renal Tumors in Children: Primary Renal Myoepithelial Carcinomas with a Novel Ewsr1-Klf15 Fusion. Am J Surg Pathol. 2016; 40:386-94.
  30. Cajaiba MM, Khanna G, Smith EA, Gellert L, Chi YY, Mullen EA, Hill DA, Geller JI, Dome JS, Perlman EJ. Pediatric Cystic Nephromas: Distinctive Features and Frequent Dicer1 Mutations. Hum Pathol. 2016; 48:81-7.
  31. Chlon TM, Ruiz-Torres S, Maag L, Mayhew CN, Wikenheiser-Brokamp KA, Davies SM, Mehta P, Myers KC, Wells JM, Wells SI. Overcoming Pluripotent Stem Cell Dependence on the Repair of Endogenous DNA Damage. Stem Cell Reports. 2016; 6:44-54.
  32. Chonat S, Chandrakasan S, Kalinyak K, Ingala D, Gruppo R, Kalfa T. Atypical Haemolytic Uraemic Syndrome in a Patient with Sickle Cell Disease, Successfully Treated with Eculizumab. Br J Haematol. 2016.
  33. Cohen R, Smith E, Arbabi S, Quinn C, Franco R. Do Red Blood Cell Indices Explain Racial Differences in the Relationship between Hemoglobin A1c and Blood Glucose? J Pediatr. 2016; 176:7-9.
  34. Comi AM, Sahin M, Hammill A, Kaplan EH, Juhasz C, North P, Ball KL, Levin AV, Cohen B, Morris J, Lo W, Roach ES, Sturge-Weber Syndrome Research Workshop. Leveraging a Sturge-Weber Gene Discovery: An Agenda for Future Research. Pediatr Neurol. 2016; 58:12-24.
  35. Conry RM, Rodriguez MG, Pressey JG. Zoledronic Acid in Metastatic Osteosarcoma: Encouraging Progression Free Survival in Four Consecutive Patients. Clin Sarcoma Res. 2016; 6:6.
  36. Cramer SL, Wei S, Merrow AC, Pressey JG. Gorham-Stout Disease Successfully Treated with Sirolimus and Zoledronic Acid Therapy. J Pediatr Hematol Oncol. 2016; 38:e129-32.
  37. Dahl NA, Michaels ST, McMasters RL, Chandra S, O'Brien MM. Azacitidine and Sorafenib Therapy in a Pediatric Patient with Refractory Acute Myeloid Leukemia with Monosomy 7 and Somatic Ptpn11 Mutation. Pediatr Blood Cancer. 2016; 63:551-3.
  38. Dandoy CE, Hariharan S, Weiss B, Demmel K, Timm N, Chiarenzelli J, Dewald MK, Kennebeck S, Langworthy S, Pomales J, Rineair S, Sandfoss E, Volz-Noe P, Nagarajan R, Alessandrini E. Sustained Reductions in Time to Antibiotic Delivery in Febrile Immunocompromised Children: Results of a Quality Improvement Collaborative. BMJ Qual Saf. 2016; 25:100-9.
  39. Dandoy CE, Haslam D, Lane A, Jodele S, Demmel K, El-Bietar J, Flesch L, Myers KC, Pate A, Rotz S, Daniels P, Wallace G, Nelson A, Waters H, Connelly B, Davies SM. Healthcare Burden, Risk Factors, and Outcomes of Mucosal Barrier Injury Laboratory-Confirmed Bloodstream Infections after Stem Cell Transplantation. Biol Blood Marrow Transplant. 2016; 22:1671-7.
  40. Dandoy CE, Linscott LL, Davies SM, Leach JL, Myers KC, El-Bietar J, Chima RS, Pate A, Nelson A, Wallace G, Wong HR, Jodele S. Clinical Utility of Computed Tomography and Magnetic Resonance Imaging for Diagnosis of Posterior Reversible Encephalopathy Syndrome after Stem Cell Transplantation in Children and Adolescents. Biol Blood Marrow Transplant. 2015; 21:2028-32.
  41. Dasgupta B, Chhipa RR. Evolving Lessons on the Complex Role of Ampk in Normal Physiology and Cancer. Trends Pharmacol Sci. 2016; 37:192-206.
  42. Davis J, Kreppel A, Brady R, Jones B, Stevenson C, Fouladi M, Hummel T. Nocardia Farcinica Meningitis Masquerading as Central Nervous System Metastasis in a Child with Cerebellar Pilocytic Astrocytoma. J Pediatr Hematol Oncol. 2015; 37:482-85.
  43. Denkinger MD, Leins H, Schirmbeck R, Florian MC, Geiger H. Hsc Aging and Senescent Immune Remodeling. Trends Immunol. 2015; 36:815-24.
  44. Diao HJ, Low WC, Lu QR, Chew SY. Topographical Effects on Fiber-Mediated Microrna Delivery to Control Oligodendroglial Precursor Cells Development. Biomaterials. 2015; 70:105-14.
  45. Dome J, Graf N, Geller J, Fernandez C, Mullen E, Spreafico F, Van den H-E, M, Pritchard-Jones K. Advances in Wilms Tumor Treatment and Biology: Progress through International Collaboration. J Clin Oncol. 2015; 33:2999-U94.
  46. Dong M, McGann PT, Mizuno T, Ware RE, Vinks AA. Development of a Pharmacokinetic-Guided Dose Individualization Strategy for Hydroxyurea Treatment in Children with Sickle Cell Anaemia. Br J Clin Pharmacol. 2016; 81:742-52.
  47. Dries DR, Zhu Y, Brooks MM, Forero DA, Adachi M, Cenik B, West JM, Han YH, Yu C, Arbella J, Nordin A, Adolfsson R, Del-Favero J, Lu QR, Callaerts P, Birnbaum SG, Yu G. Loss of Nicastrin from Oligodendrocytes Results in Hypomyelination and Schizophrenia with Compulsive Behavior. J Biol Chem. 2016; 291:11647-56.
  48. Du W, Amarachintha S, Erden O, Wilson A, Meetei AR, Andreassen PR, Namekawa SH, Pang Q. Fancb Deficiency Impairs Hematopoietic Stem Cell Function. Sci Rep. 2015; 5:18127.
  49. Du W, Amarachintha S, Wilson AF, Pang Q. Hyper-Active Non-Homologous End Joining Selects for Synthetic Lethality Resistant and Pathological Fanconi Anemia Hematopoietic Stem and Progenitor Cells. Sci Rep. 2016; 6:22167.
  50. Du W, Amarachintha S, Wilson AF, Pang Q. Sco2 Mediates Oxidative Stress-Induced Glycolysis to Oxidative Phosphorylation Switch in Hematopoietic Stem Cells. Stem Cells. 2016; 34:960-71.
  51. Ehrlich PF, Hamilton TE, Gow K, Barnhart D, Ferrer F, Kandel J, Glick R, Dasgupta R, Naranjo A, He Y, Perlman EJ, Kalapurakal JA, Khanna G, Dome JS, Geller J, Mullen E. Surgical Protocol Violations in Children with Renal Tumors Provides an Opportunity to Improve Pediatric Cancer Care: A Report from the Children's Oncology Group. Pediatr Blood Cancer. 2016; 63:1905-10.
  52. El-Bietar J, Nelson A, Wallace G, Dandoy C, Jodele S, Myers K, Teusink A, Lane A, Davies S, Danziger-Isakov L. Rsv Infection without Ribavirin Treatment in Pediatric Hematopoietic Stem Cell Transplantation. Bone Marrow Transplant. 2016.
  53. El-Bietar J, Warren M, Dandoy C, Myers KC, Lane A, Wallace G, Davies SM, Jodele S. Histologic Features of Intestinal Thrombotic Microangiopathy in Pediatric and Young Adult Patients after Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant. 2015; 21:1994-2001.
  54. Emery B, Lu QR. Transcriptional and Epigenetic Regulation of Oligodendrocyte Development and Myelination in the Central Nervous System. Cold Spring Harb Perspect Biol. 2015; 7:a020461.
  55. Englum BR, Rothman J, Leonard S, Reiter A, Thornburg C, Brindle M, Wright N, Heeney MM, Jason Smithers C, Brown RL, Kalfa T, Langer JC, Cada M, Oldham KT, Scott JP, St Peter SD, Sharma M, Davidoff AM, Nottage K, Bernabe K, et al. Hematologic Outcomes after Total Splenectomy and Partial Splenectomy for Congenital Hemolytic Anemia. J Pediatr Surg. 2016; 51:122-7.
  56. Fang J, Starczynowski DT. Genomic Instability Establishes Dependencies on Acquired Gene Regulatory Networks: A Novel Role of P62 in Myeloid Malignancies with Del(5q). Mol Cell Oncol. 2015; 2:e1014219.
  57. Filippi M. Leukocyte Transcellular Diapedesis: Rap1b Is in Control. Tissue Barriers. 2015; 3:e1052185.
  58. Filippi M. Neutrophil Actin Regulation: Mkl1 Is in Control. Blood. 2015; 126:1519-20.
  59. Filippi MD. Mechanism of Diapedesis: Importance of the Transcellular Route. Adv Immunol. 2016; 129:25-53.
  60. Flood VH, Christopherson PA, Gill JC, Friedman KD, Haberichter SL, Bellissimo DB, Udani RA, Dasgupta M, Hoffmann RG, Ragni MV, Shapiro AD, Lusher JM, Lentz SR, Abshire TC, Leissinger C, Hoots WK, Manco-Johnson MJ, Gruppo RA, Boggio LN, Montgomery KT, et al. Clinical and Laboratory Variability in a Cohort of Patients Diagnosed with Type 1 Vwd in the United States. Blood. 2016; 127:2481-8.
  61. Gaballah M, Shi J, Kukreja K, Raffini L, Tarango C, Keller M, Krishnamurthy G, Racadio J, Patel M, Cahill AM. Endovascular Thrombolysis in the Management of Iliofemoral Thrombosis in Children: A Multi-Institutional Experience. J Vasc Interv Radiol. 2016; 27:524-30.
  62. Gañán-Gómez I, Wei Y, Starczynowski DT, Colla S, Yang H, Cabrero-Calvo M, Bohannan ZS, Verma A, Steidl U, Garcia-Manero G. Deregulation of Innate Immune and Inflammatory Signaling in Myelodysplastic Syndromes. Leukemia. 2015; 29:1458-69.
  63. Geiger H. Depleting Senescent Cells to Combat Aging. Nat Med. 2016; 22:23-4.
  64. Stem Cell Aging: Mechanisms, Consequences, Rejuvenation. Vienna:Springer.
  65. Geller JI. Current Standards of Care and Future Directions for "High-Risk" Pediatric Renal Tumors: Anaplastic Wilms Tumor and Rhabdoid Tumor. Urol Oncol. 2016; 34:50-6.
  66. Geller JI, Ehrlich PF, Cost NG, Khanna G, Mullen EA, Gratias EJ, Naranjo A, Dome JS, Perlman EJ. Characterization of Adolescent and Pediatric Renal Cell Carcinoma: A Report from the Children's Oncology Group Study Aren03b2. Cancer. 2015; 121:2457-64.
  67. Gentner B, Pochert N, Rouhi A, Boccalatte F, Plati T, Berg T, Sun SM, Mah SM, Mirkovic-Hösle M, Ruschmann J, Muranyi A, Leierseder S, Argiropoulos B, Starczynowski DT, Karsan A, Heuser M, Hogge D, Camargo FD, Engelhardt S, Dohner H, et al. Microrna-223 Dose Levels Fine Tune Proliferation and Differentiation in Human Cord Blood Progenitors and Acute Myeloid Leukemia. Exp Hematol. 2015; 43:858-68 e7.
  68. Giger KM, Kalfa TA. Phylogenetic and Ontogenetic View of Erythroblastic Islands. Biomed Res Int. 2015; 2015:873628.
  69. Glait-Santar C, Desmond R, Feng X, Bat T, Chen J, Heuston E, Mizukawa B, Mulloy J, Bodine D, Larochelle A. Functional Niche Competition between Normal Hematopoietic Stem and Progenitor Cells and Myeloid Leukemia Cells. Stem Cells. 2015; 33:3635-42.
  70. Goldenberg NA, Abshire T, Blatchford PJ, Fenton LZ, Halperin JL, Hiatt WR, Kessler CM, Kittelson JM, Manco-Johnson MJ, Spyropoulos AC, Steg PG, Stence NV, Turpie AG, Schulman S, Kids Dott Trial Investigators. Multicenter Randomized Controlled Trial on Duration of Therapy for Thrombosis in Children and Young Adults (the Kids-Dott Trial): Pilot/Feasibility Phase Findings. J Thromb Haemost. 2015; 13:1597-605.
  71. Gonsalves C, Li C, Malik P, Tahara S, Kalra V. Peroxisome Proliferator-Activated Receptor-?-Mediated Transcription of Mir-301a and Mir-454 and Their Host Gene Ska2 Regulates Endothelin-1 and Pai-1 Expression in Sickle Cell Disease. pmc/PMC4672349. Bioscience Reports. 2015; 35.
  72. Goyama S, Huang G, Kurokawa M, Mulloy J. Posttranslational Modifications of Runx1 as Potential Anticancer Targets. Oncogene. 2015; 34:3483-92.
  73. Goyama S, Schibler J, Gasilina A, Shrestha M, Lin S, Link KA, Chen J, Whitman SP, Bloomfield CD, Nicolet D, Assi SA, Ptasinska A, Heidenreich O, Bonifer C, Kitamura T, Nassar NN, Mulloy JC. Ubash3b/Sts-1-Cbl Axis Regulates Myeloid Proliferation in Human Preleukemia Induced by Aml1-Eto. Leukemia. 2016; 30:728-39.
  74. Gururangan S, Robinson G, Ellison DW, Wu G, He X, Lu QR, McLendon R, Grant G, Driscoll T, Neuberg R. Gorlin Syndrome and Desmoplastic Medulloblastoma: Report of 3 Cases with Unfavorable Clinical Course and Novel Mutations. Pediatr Blood Cancer. 2015; 62:1855-8.
  75. Haas S, Hansson J, Klimmeck D, Loeffler D, Velten L, Uckelmann H, Wurzer S, Prendergast AM, Schnell A, Hexel K, Santarella-Mellwig R, Blaszkiewicz S, Kuck A, Geiger H, Milsom MD, Steinmetz LM, Schroeder T, Trumpp A, Krijgsveld J, Essers MA. Inflammation-Induced Emergency Megakaryopoiesis Driven by Hematopoietic Stem Cell-Like Megakaryocyte Progenitors. Cell Stem Cell. 2015; 17:422-34.
  76. Hankins JS, McCarville MB, Rankine-Mullings A, Reid ME, Lobo CL, Moura PG, Ali S, Soares DP, Aldred K, Jay DW, Aygun B, Bennett J, Kang G, Goldsmith JC, Smeltzer MP, Boyett JM, Ware RE. Prevention of Conversion to Abnormal Transcranial Doppler with Hydroxyurea in Sickle Cell Anemia: A Phase Iii International Randomized Clinical Trial. Am J Hematol. 2015; 90:1099-105.
  77. He D, Marie C, Zhao C, Kim B, Wang J, Deng Y, Clavairoly A, Frah M, Wang H, He X, Hmidan H, Jones BV, Witte D, Zalc B, Zhou X, Choo DI, Martin DM, Parras C, Lu QR. Chd7 Cooperates with Sox10 and Regulates the Onset of Cns Myelination and Remyelination. Nat Neurosci. 2016; 19:678-89.
  78. Hoffman L, DeWire M, Ryall S, Buczkowicz P, Leach J, Miles L, Ramani A, Brudno M, Kumar S, Drissi R. Spatial Genomic Heterogeneity in Diffuse Intrinsic Pontine and Midline High-Grade Glioma: Implications for Diagnostic Biopsy and Targeted Therapeutics. pmc/PMC4700584. Acta Neuropathologica Communications. 2016; 4:1.
  79. Hoffman LM, Fouladi M, Olson J, Daryani VM, Stewart CF, Wetmore C, Kocak M, Onar-Thomas A, Wagner L, Gururangan S, Packer RJ, Blaney SM, Gajjar A, Kun LE, Boyett JM, Gilbertson RJ. Phase I Trial of Weekly Mk-0752 in Children with Refractory Central Nervous System Malignancies: A Pediatric Brain Tumor Consortium Study. Childs Nerv Syst. 2015; 31:1283-9.
  80. Holle JR, Marsh RA, Holdcroft AM, Davies SM, Wang LJ, Zhang KJ, Jordan MB. Hemophagocytic Lymphohistiocytosis in a Female Patient Due to a Heterozygous Xiap Mutation and Skewed X Chromosome Inactivation. Pediatr Blood Cancer. 2015; 62:1288-90.
  81. Huang Y, Shaw M, Warmin M, Mullins E, Ayres N. Blood Compatibility of Heparin-Inspired, Lactose Containing, Polyureas Depends on the Chemistry of the Polymer Backbone. Polym Chem. 2016; 7:3897-905.
  82. Hummel TR, Salloum R, Drissi R, Kumar S, Sobo M, Goldman S, Pai A, Leach J, Lane A, Pruitt D, Sutton M, Chow LM, Grimme L, Doughman R, Backus L, Miles L, Stevenson C, Fouladi M, DeWire M. A Pilot Study of Bevacizumab-Based Therapy in Patients with Newly Diagnosed High-Grade Gliomas and Diffuse Intrinsic Pontine Gliomas. J Neurooncol. 2016; 127:53-61.
  83. Imai F, Ladle D, Leslie J, Duan X, Rizvi T, Ciraolo G, Zheng Y, Yoshida Y. Synapse Formation in Monosynaptic Sensory-Motor Connections Is Regulated by Presynaptic Rho Gtpase Cdc42. J Neurosci. 2016; 36:5724-35.
  84. Jodele S, Dandoy CE, Myers KC, El-Bietar J, Nelson A, Wallace G, Laskin BL. New Approaches in the Diagnosis, Pathophysiology, and Treatment of Pediatric Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy. Transfus Apher Sci. 2016; 54:181-90.
  85. Jodele S, Fukuda T, Mizuno K, Vinks AA, Laskin BL, Goebel J, Dixon BP, Chima RS, Hirsch R, Teusink A, Lazear D, Lane A, Myers KC, Dandoy CE, Davies SM. Variable Eculizumab Clearance Requires Pharmacodynamic Monitoring to Optimize Therapy for Thrombotic Microangiopathy after Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant. 2016; 22:307-15.
  86. Jodele S, Zhang K, Zou F, Laskin B, Dandoy CE, Myers KC, Lane A, Meller J, Medvedovic M, Chen J, Davies SM. The Genetic Fingerprint of Susceptibility for Transplant-Associated Thrombotic Microangiopathy. Blood. 2016; 127:989-96.
  87. Jones BV, Linscott L, Koberlein G, Hummel TR, Leach JL. Increased Prevalence of Developmental Venous Anomalies in Children with Intracranial Neoplasms. AJNR Am J Neuroradiol. 2015; 36:1782-5.
  88. Joshi N, Kopec A, Ray J, Cline-Fedewa H, Nawabi A, Schmitt T, Nault R, Zacharewski T, Rockwell C, Flick M. Fibrin Deposition Following Bile Duct Injury Limits Fibrosis through an Alpha(M)Beta(2)-Dependent Mechanism. Blood. 2016; 127:2751-62.
  89. Jousma E, Rizvi TA, Wu J, Janhofer D, Dombi E, Dunn RS, Kim MO, Masters AR, Jones DR, Cripe TP, Ratner N. Preclinical Assessments of the Mek Inhibitor Pd-0325901 in a Mouse Model of Neurofibromatosis Type 1. Pediatr Blood Cancer. 2015; 62:1709-16.
  90. Juarez A, He D, Lu Q. Oligodendrocyte Progenitor Programming and Reprogramming: Toward Myelin Regeneration. Brain Research. 2016; 1638:209-20.
  91. Kannan JA, Davila-Saldana BJ, Zhang K, Filipovich AH, Kucuk ZY. Activated Phosphoinositide 3-Kinase Delta Syndrome in a Patient with a Former Diagnosis of Common Variable Immune Deficiency, Bronchiectasis, and Lymphoproliferative Disease. Ann Allergy Asthma Immunol. 2015; 115:452-4.
  92. Kato Y, Alavattam K, Sin H-S, Meetei A, Pang Q, Andreassen P, Namekawa S. Fancb Is Essential in the Male Germline and Regulates H3k9 Methylation on the Sex Chromosomes During Meiosis. Hum Mol Genet. 2015; 24:5234-49.
  93. Kesarwani M, Huber E, Kincaid Z, Evelyn CR, Biesiada J, Rance M, Thapa MB, Shah NP, Meller J, Zheng Y, Azam M. Targeting Substrate-Site in Jak2 Kinase Prevents Emergence of Genetic Resistance. Sci Rep. 2015; 5:14538.
  94. Khandelwal P, Lane A, Chaturvedi V, Owsley E, Davies SM, Marmer D, Filipovich AH, Jordan MB, Marsh RA. Peripheral Blood Cd38 Bright Cd8+ Effector Memory T Cells Predict Acute Graft-Versus-Host Disease. Biol Blood Marrow Transplant. 2015; 21:1215-22.
  95. Khandelwal P, Mellor-Heineke S, Rehman N, Lane A, Smiley K, Villanueva J, Marsh RA, Grimley MS, Davies SM, Filipovich AH. Cytokine Profile of Engraftment Syndrome in Pediatric Hematopoietic Stem Cell Transplant Recipients. Biol Blood Marrow Transplant. 2016; 22:690-7.
  96. Khandelwal P, Smiley K, Fieno A, Grant R, Davies S. Cxcl10 Can Be Detected Non-Invasively from the Skin of Children with Acute Skin Gvhd. Bone Marrow Transplant. 2016.
  97. Kieran MW, Chi S, Goldman S, Onar-Thomas A, Poussaint TY, Vajapeyam S, Fahey F, Wu S, Turner DC, Stewart CF, Moses M, Packer RJ, Jakacki R, Banerjee A, Boyett JM, Fouladi M, Kun L. A Phase I Trial and Pk Study of Cediranib (Azd2171), an Orally Bioavailable Pan-Vegfr Inhibitor, in Children with Recurrent or Refractory Primary Cns Tumors. Childs Nerv Syst. 2015; 31:1433-45.
  98. Kim MO, Wang X, Liu C, Dorris K, Fouladi M, Song S. Random-Effects Meta-Analysis for Systematic Reviews of Phase I Clinical Trials: Rare Events and Missing Data. Res Synth Methods. 2016.
  99. Kim S-H, Ezhilarasan R, Phillips E, Gallego-Perez D, Sparks A, Taylor D, Ladner K, Furuta T, Sabit H, Chhipa R. Serine/Threonine Kinase Mlk4 Determines Mesenchymal Identity in Glioma Stem Cells in an Nf-Kappa B-Dependent Manner. Cancer Cell. 2016; 29:201-13.
  100. King AA, Kamani N, Bunin N, Sahdev I, Brochstein J, Hayashi RJ, Grimley M, Abraham A, Dioguardi J, Chan KW, Douglas D, Adams R, Andreansky M, Anderson E, Gilman A, Chaudhury S, Yu L, Dalal J, Hale G, Cuvelier G, et al. Successful Matched Sibling Donor Marrow Transplantation Following Reduced Intensity Conditioning in Children with Hemoglobinopathies. Am J Hematol. 2015; 90:1093-8.
  101. Klionsky D, Abdelmohsen K, Abe A, Abedin M, Abeliovich H, Arozena A, Adachi H, Adams C, Adams P, Adeli Kea. Guidelines for the Use and Interpretation of Assays for Monitoring Autophagy (3rd Edition). Autophagy. 2016; 12:1-222.
  102. Ko Y-P, Flick M. Fibrinogen Is at the Interface of Host Defense and Pathogen Virulence in Staphylococcus Aureus Infection. Semin Thromb Hemost. 2016; 42:408-21.
  103. Komurov K. Computational Approaches to Modeling of Molecular Interactions in Multicellular Systems. In: K M, ed. Intercellular Communication in Cancer. Dordrecht: Springer Netherlands; 2015:287-96.
  104. Konstantinidis DG, Giger KM, Risinger M, Pushkaran S, Zhou P, Dexheimer P, Yerneni S, Andreassen P, Klingmuller U, Palis J, Zheng Y, Kalfa TA. Cytokinesis Failure in Rhoa-Deficient Mouse Erythroblasts Involves Actomyosin and Midbody Dysregulation and Triggers P53 Activation. Blood. 2015; 126:1473-82.
  105. Kucuk ZY, Bleesing JJ, Marsh R, Zhang K, Davies S, Filipovich AH. A Challenging Undertaking: Stem Cell Transplantation for Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked (Ipex) Syndrome. J Allergy Clin Immunol. 2016; 137:953-5 e4.
  106. Laitman B, Asp L, Mariani J, Zhang J, Liu J, Sawai S, Chapouly C, Horng S, Kramer E, Mitiku N. The Transcriptional Activator Kruppel-Like Factor-6 Is Required for Cns Myelination. Plos Biology. 2016; 14.
  107. Laskin BL, Singh HK, Beier UH, Moatz T, Furth SL, Bunin N, Witte D, Goebel J, Davies SM, Dandoy C, Jodele S, Nickeleit V. The Noninvasive Urinary Polyomavirus Haufen Test Predicts Bk Virus Nephropathy in Children after Hematopoietic Cell Transplantation: A Pilot Study. Transplantation. 2016; 100:e81-7.
  108. Laskin BL, Sullivan KE, Hester J, Goebel J, Davies SM, Jodele S. Antibodies to Bk Virus in Children Prior to Allogeneic Hematopoietic Cell Transplant. Pediatr Blood Cancer. 2015; 62:1670-3.
  109. Lazaryan A, Wang T, Spellman SR, Wang HL, Pidala J, Nishihori T, Askar M, Olsson R, Oudshoorn M, Abdel-Azim H, Yong A, Gandhi M, Dandoy C, Savani B, Hale G, Page K, Bitan M, Reshef R, Drobyski W, Marsh SG, et al. Human Leukocyte Antigen Supertype Matching after Myeloablative Hematopoietic Cell Transplantation with 7/8 Matched Unrelated Donor Allografts: A Report from the Center for International Blood and Marrow Transplant Research. Haematologica. 2016.
  110. Li H, Zhao X, Yan X, Jessen WJ, Kim MO, Dombi E, Liu PP, Huang G, Wu J. Runx1 Contributes to Neurofibromatosis Type 1 Neurofibroma Formation. Oncogene. 2016; 35:1468-74.
  111. Lin Y, Zheng Y. Approaches of Targeting Rho Gtpases in Cancer Drug Discovery. Expert Opin Drug Discov. 2015; 10:991-1010.
  112. Lindsley AW, Saal HM, Burrow TA, Hopkin RJ, Shchelochkov O, Khandelwal P, Xie C, Bleesing J, Filipovich L, Risma K, Assa'ad AH, Roehrs PA, Bernstein JA. Defects of B-Cell Terminal Differentiation in Patients with Type-1 Kabuki Syndrome. J Allergy Clin Immunol. 2016; 137:179-87 e10.
  113. Ljung R, Kenet G, Mancuso ME, Kaleva V, Rusen L, Tseneklidou-Stoeter D, Michaels LA, Shah A, Hong W, Maas Enriquez M, Investigators of the Leopold Kids Trial. Bay 81-8973 Safety and Efficacy for Prophylaxis and Treatment of Bleeds in Previously Treated Children with Severe Haemophilia A: Results of the Leopold Kids Trial. Haemophilia. 2016; 22:354-60.
  114. Lo B, Zhang KJ, Lu W, Zheng LX, Zhang Q, Kanellopoulou C, Zhang Y, Liu ZD, Fritz JM, Marsh R, Husami A, Kissell D, Nortman S, Chaturvedi V, Haines H, Young LR, Mo J, Filipovich AH, Bleesing JJ, Mustillo P, et al. Patients with Lrba Deficiency Show Ctla4 Loss and Immune Dysregulation Responsive to Abatacept Therapy. Science. 2015; 349:436-40.
  115. Loiselle K, Rausch J, Bidwell S, Drake S, Davies S, Pai A. Predictors of Health-Related Quality of Life over Time among Pediatric Hematopoietic Stem Cell Transplant Recipients. Pediatr Blood Cancer. 2016.
  116. Lu F, Chen Y, Zhao C, Wang H, He D, Xu L, Wang J, He X, Deng Y, Lu EE, Liu X, Verma R, Bu H, Drissi R, Fouladi M, Stemmer-Rachamimov AO, Burns D, Xin M, Rubin JB, Bahassi el M, et al. Olig2-Dependent Reciprocal Shift in Pdgf and Egf Receptor Signaling Regulates Tumor Phenotype and Mitotic Growth in Malignant Glioma. Cancer Cell. 2016; 29:669-83.
  117. Luchtman-Jones L, Pressel S, Hilliard L, Brown RC, Smith MG, Thompson AA, Lee MT, Rothman J, Rogers ZR, Owen W, Imran H, Thornburg C, Kwiatkowski JL, Aygun B, Nelson S, Roberts C, Gauger C, Piccone C, Kalfa T, Alvarez O, et al. Effects of Hydroxyurea Treatment for Patients with Hemoglobin Sc Disease. Am J Hematol. 2016; 91:238-42.
  118. Lulla RR, Goldman S, Yamada T, Beattie CW, Bressler L, Pacini M, Pollack IF, Fisher PG, Packer RJ, Dunkel IJ, Dhall G, Wu S, Onar A, Boyett JM, Fouladi M. Phase I Trial of P28 (Nsc745104), a Non-Hdm2-Mediated Peptide Inhibitor of P53 Ubiquitination in Pediatric Patients with Recurrent or Progressive Central Nervous System Tumors: A Pediatric Brain Tumor Consortium Study. Neuro Oncol. 2016; 18:1319-25.
  119. Maiques-Diaz A, Hernando M, Sanchez-Lopez A, Rio-Machin A, Shrestha M, Mulloy J, Cigudosa J, Alvarez S. Mapk8-Mediated Stabilization of Sp1 Is Essential for Runx1-Runx1t1-Driven Leukaemia. Brit J Haematol. 2016; 172:807-10.
  120. Malik P. Gene Therapy for Hemoglobinopathies: Tremendous Successes and Remaining Caveats. Mol Ther. 2016; 24:668-70.
  121. Marsh R, Rao M, Gefen A, Bellman D, Mehta P, Khandelwal P, Chandra S, Jodele S, Myers K, Grimley M. Experience with Alemtuzumab, Fludarabine, and Melphalan Reduced-Intensity Conditioning Hematopoietic Cell Transplantation in Patients with Nonmalignant Diseases Reveals Good Outcomes and That the Risk of Mixed Chimerism Depends on Underlying Disease, Stem Cell Source, and Alemtuzumab Regimen. Biol Blood Marrow Transplant. 2015; 21:1460-70.
  122. Marsh RA, Lane A, Mehta PA, Neumeier L, Jodele S, Davies SM, Filipovich AH. Alemtuzumab Levels Impact Acute Gvhd, Mixed Chimerism, and Lymphocyte Recovery Following Alemtuzumab, Fludarabine, and Melphalan Ric Hct. Blood. 2016; 127:503-12.
  123. Matrka MC, Hennigan RF, Kappes F, DeLay ML, Lambert PF, Aronow BJ, Wells SI. Dek over-Expression Promotes Mitotic Defects and Micronucleus Formation. Cell Cycle. 2015; 14:3939-53.
  124. McCarthy CE, O'Brien M, Andrews J, Zoland JM, Macasiray E, Wong W, Lo C, Glader B, Tamaresis J, Jeng M. Updated Analysis: Central Venous Access Device Infection Rates in an Expanded Cohort of Paediatric Patients with Severe Haemophilia Receiving Prophylactic Recombinant Tissue Plasminogen Activator. Haemophilia. 2016; 22:81-6.
  125. McGann P. Time to Invest in Sickle Cell Anemia as a Global Health Priority. Pediatr Ann. 2016; 137:e 20160348.
  126. McGann P. Improving Survival for Children with Sickle Cell Disease: Newborn Screening Is Only the First Step. Paediatr Int Child Health. 2015; 35:285-86.
  127. McGann P, Ware R. Hydroxyurea Therapy for Sickle Cell Anemia. Expert Opin Drug Saf. 2015; 14:1749-58.
  128. McGann PT. Hydroxyurea for Abnormal Tcds: Safe to Switch? Blood. 2016; 127:1738-40.
  129. McGann PT, Grosse SD, Santos B, de Oliveira V, Bernardino L, Kassebaum NJ, Ware RE, Airewele GE. A Cost-Effectiveness Analysis of a Pilot Neonatal Screening Program for Sickle Cell Anemia in the Republic of Angola. J Pediatr. 2015; 167:1314-9.
  130. McGann PT, Schaefer BA, Paniagua M, Howard TA, Ware RE. Characteristics of a Rapid, Point-of-Care Lateral Flow Immunoassay for the Diagnosis of Sickle Cell Disease. Am J Hematol. 2016; 91:205-10.
  131. McGann PT, Tshilolo L, Santos B, Tomlinson GA, Stuber S, Latham T, Aygun B, Obaro SK, Olupot-Olupot P, Williams TN, Odame I, Ware RE, Reach Investigators. Hydroxyurea Therapy for Children with Sickle Cell Anemia in Sub-Saharan Africa: Rationale and Design of the Reach Trial. Pediatr Blood Cancer. 2016; 63:98-104.
  132. McGann PT, Tyburski EA, de Oliveira V, Santos B, Ware RE, Lam WA. An Accurate and Inexpensive Color-Based Assay for Detecting Severe Anemia in a Limited-Resource Setting. Am J Hematol. 2015; 90:1122-7.
  133. Mehta P, Davies S. Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia in Children. In: S Forman, R Negrin, J Antin, F Applebaum, eds. Thomas' Hematopoietic Cell Transplantation: Fifth Edition. New York: John Wiley & Sons; 2016:600-17.
  134. Mehta PA, Zhang MJ, Eapen M, He W, Seber A, Gibson B, Camitta BM, Kitko CL, Dvorak CC, Nemecek ER, Frangoul HA, Abdel-Azim H, Kasow KA, Lehmann L, Gonzalez Vicent M, Diaz Perez MA, Ayas M, Qayed M, Carpenter PA, Jodele S, et al. Transplantation Outcomes for Children with Hypodiploid Acute Lymphoblastic Leukemia. Biol Blood Marrow Transplant. 2015; 21:1273-7.
  135. Michaels ST, Abruzzo TA, Augsburger JJ, Correa ZM, Lane A, Geller JI. Selective Ophthalmic Artery Infusion Chemotherapy for Advanced Intraocular Retinoblastoma: Cchmc Early Experience. J Pediatr Hematol Oncol. 2016; 38:65-9.
  136. Moehrle B, Nattamai K, Brown A, Florian M, Ryan M, Vogel M, Bliederhaeuser C, Soller K, Prows D, Abdollahi A. Stem Cell-Specific Mechanisms Ensure Genomic Fidelity within Hscs and Upon Aging of Hscs. Cell Rep. 2015; 13:2412-24.
  137. Moradi M, D, Malik P. The Current State-of-the-Art in Therapeutic Genome Editing and the Future. Gene Technol. 2016; 05.
  138. Motley MP, Madsen DH, Jurgensen HJ, Spencer DE, Szabo R, Holmbeck K, Flick MJ, Lawrence DA, Castellino FJ, Weigert R, Bugge TH. A Ccr2 Macrophage Endocytic Pathway Mediates Extravascular Fibrin Clearance in Vivo. Blood. 2016; 127:1085-96.
  139. Mpollo M-S, Brandt E, Shanmukhappa S, Arumugam P, Tiwari S, Loberg A, Pillis D, Rizvi T, Lindsey M, Jonck B. Placenta Growth Factor Augments Airway Hyperresponsiveness Via Leukotrienes and Il-13. J Clin Invest. 2016; 126:571-84.
  140. Mullins TL, Miller RJ, Mullins ES. Evaluation and Management of Adolescents with Abnormal Uterine Bleeding. Pediatr Ann. 2015; 44:e218-22.
  141. Nasimuzzaman M, Lynn D, Ernst R, Beuerlein M, Smith R, Shrestha A, Cross S, Link K, Lutzko C, Nordling D. Production and Purification of High-Titer Foamy Virus Vector for the Treatment of Leukocyte Adhesion Deficiency. Mol Ther Methods Clin Dev. 2016; 3.
  142. Nayak RC, Trump LR, Aronow BJ, Myers K, Mehta P, Kalfa T, Wellendorf AM, Valencia CA, Paddison PJ, Horwitz MS, Grimes HL, Lutzko C, Cancelas JA. Pathogenesis of Elane-Mutant Severe Neutropenia Revealed by Induced Pluripotent Stem Cells. J Clin Invest. 2015; 125:3103-16.
  143. Ndeezi G, Kiyaga C, Hernandez AG, Munube D, Howard TA, Ssewanyana I, Nsungwa J, Kiguli S, Ndugwa CM, Ware RE, Aceng JR. Burden of Sickle Cell Trait and Disease in the Uganda Sickle Surveillance Study (Us3): A Cross-Sectional Study. Lancet Glob Health. 2016; 4:e195-200.
  144. Nelson AS, Marsh RA, Myers KC, Davies SM, Jodele S, O'Brien TA, Mehta PA. A Reduced-Intensity Conditioning Regimen for Patients with Dyskeratosis Congenita Undergoing Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant. 2016; 22:884-8.
  145. Ngoc-Tung T, Su H, Khodadadi-Jamayran A, Lin S, Zhang L, Zhou D, Pawlik K, Townes T, Chen Y, Mulloy J. The as-Rbm15 Lncrna Enhances Rbm15 Protein Translation During Megakaryocyte Differentiation. Embo Reports. 2016; 17:887-900.
  146. Niss O, Quinn CT, Lane A, Daily J, Khoury PR, Bakeer N, Kimball TR, Towbin JA, Malik P, Taylor MD. Cardiomyopathy with Restrictive Physiology in Sickle Cell Disease. JACC Cardiovasc Imaging. 2016; 9:243-52.
  147. Nohata N, Uchida Y, Stratman AN, Adams RH, Zheng Y, Weinstein BM, Mukouyama YS, Gutkind JS. Temporal-Specific Roles of Rac1 During Vascular Development and Retinal Angiogenesis. Dev Biol. 2016; 411:183-94.
  148. Ombrello MJ, Remmers EF, Tachmazidou I, Grom A, Foell D, Haas JP, Martini A, Gattorno M, Ozen S, Prahalad S, Zeft AS, Bohnsack JFea. Antibodies Targeting Human Il1rap (Il1r3) Show Therapeutic Effects in Xenograft Models of Acute Myeloid Leukemia. Proc Natl Acad Sci U S A. 2015; 112:10786-91.
  149. Park J, Virts E, Jankowska A, Wiek C, Othman M, Chakraborty S, Vance G, Alkuraya F, Hanenberg H, Andreassen P. Complementation of Hypersensitivity to DNA Interstrand Crosslinking Agents Demonstrates That Xrcc2 Is a Fanconi Anaemia Gene. J Med Genet. 2016.
  150. Pate A, Rotz S, Warren M, Hirsch R, Cash M, Myers KC, El-Bietar J, Nelson A, Wallace G, Filipovich AH, Bleesing J, Chima RS, Davies SM, Jodele S, Dandoy CE. Pulmonary Hypertension Associated with Bronchiolitis Obliterans after Hematopoietic Stem Cell Transplantation. Bone Marrow Transplant. 2016; 51:310-2.
  151. Patel A, Johansson G, Colbert M, Dasgupta B, Ratner N. Fatty Acid Synthase Is a Metabolic Oncogene Targetable in Malignant Peripheral Nerve Sheath Tumors. Neuro-Oncology. 2015; 17:1599-608.
  152. Pietras EM, Reynaud D, Kang YA, Carlin D, Calero-Nieto FJ, Leavitt AD, Stuart JM, Gottgens B, Passegué E. Functionally Distinct Subsets of Lineage-Biased Multipotent Progenitors Control Blood Production in Normal and Regenerative Conditions. Cell Stem Cell. 2015; 17:35-46.
  153. Poussaint TY, Vajapeyam S, Ricci KI, Panigrahy A, Kocak M, Kun LE, Boyett JM, Pollack IF, Fouladi M. Apparent Diffusion Coefficient Histogram Metrics Correlate with Survival in Diffuse Intrinsic Pontine Glioma: A Report from the Pediatric Brain Tumor Consortium. Neuro Oncol. 2016; 18:725-34.
  154. Prada C, Hufnagel R, Hummel T, Lovell A, Hopkin R, Saal H, Schorry E. The Use of Magnetic Resonance Imaging Screening for Optic Pathway Gliomas in Children with Neurofibromatosis Type 1. J Pediatr 2015; 167:851.
  155. Prasad J, Gorkun O, Raghu H, Thornton S, Mullins E, Palumbo J, Ko Y-P, Höök M, David T, Coughlin S. Mice Expressing a Mutant Form of Fibrinogen That Cannot Support Fibrin Formation Exhibit Compromised Antimicrobial Host Defense. Blood. 2015; 126:2047-58.
  156. Quinn C. Do Not Leave for Tomorrow What You Can Do Today. Pediatr Blood Cancer. 2015; 62:1879-80.
  157. Quinn CT. Minireview: Clinical Severity in Sickle Cell Disease: The Challenges of Definition and Prognostication. Exp Biol Med (Maywood). 2016; 241:679-88.
  158. Quinn CT, St Pierre TG. Mri Measurements of Iron Load in Transfusion-Dependent Patients: Implementation, Challenges, and Pitfalls. Pediatr Blood Cancer. 2016; 63:773-80.
  159. Rao R, Salloum R, Xin M, Lu Q. The G Protein G Alpha(S) Acts as a Tumor Suppressor in Sonic Hedgehog Signaling-Driven Tumorigenesis. Cell Cycle. 2016; 15:1325-30.
  160. Rayes A, McMasters RL, O'Brien MM. Lineage Switch in Mll-Rearranged Infant Leukemia Following Cd19-Directed Therapy. Pediatr Blood Cancer. 2016; 63:1113-5.
  161. Rayes A, Morrow AL, Payton LR, Lake KE, Lane A, Davies SM. A Genetic Modifier of the Gut Microbiome Influences the Risk of Graft-Versus-Host Disease and Bacteremia after Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant. 2016; 22:418-22.
  162. Rivera CP, Veneziani A, Ware RE, Platt MO. Original Research: Sickle Cell Anemia and Pediatric Strokes: Computational Fluid Dynamics Analysis in the Middle Cerebral Artery. Exp Biol Med (Maywood). 2016; 241:755-65.
  163. Robinson GW, Orr BA, Wu G, Gururangan S, Lin T, Qaddoumi I, Packer RJ, Goldman S, Prados MD, Desjardins A, Chintagumpala M, Takebe N, Kaste SC, Rusch M, Allen SJ, Onar-Thomas A, Stewart CF, Fouladi M, Boyett JM, Gilbertson RJ, et al. Vismodegib Exerts Targeted Efficacy against Recurrent Sonic Hedgehog-Subgroup Medulloblastoma: Results from Phase Ii Pediatric Brain Tumor Consortium Studies Pbtc-025b and Pbtc-032. J Clin Oncol. 2015; 33:2646-54.
  164. Romick-Rosendale L, Hoskins E, Vinnedge L, Foglesong G, Brusadelli M, Potter S, Komurov K, Brugmann S, Lambert P, Kimple R. Defects in the Fanconi Anemia Pathway in Head and Neck Cancer Cells Stimulate Tumor Cell Invasion through DNA-Pk and Rac1 Signaling. Clin Cancer Res. 2016; 22:2062-73.
  165. Rossi E, Smadja DM, Boscolo E, Langa C, Arevalo MA, Pericacho M, Gamella-Pozuelo L, Kauskot A, Botella LM, Gaussem P, Bischoff J, Lopez-Novoa JM, Bernabeu C. Endoglin Regulates Mural Cell Adhesion in the Circulatory System. Cell Mol Life Sci. 2016; 73:1715-39.
  166. Rutter MM, Jha P, Schultz KA, Sheil A, Harris AK, Bauer AJ, Field AL, Geller J, Hill DA. Dicer1 Mutations and Differentiated Thyroid Carcinoma: Evidence of a Direct Association. J Clin Endocrinol Metab. 2016; 101:1-5.
  167. Ryan T, Jefferies J, Chin C, Sticka J, Taylor M, Harris R, Moore J, Goodridge E, Mount L, Bolyard A. Abnormal Circumferential Strain Measured by Echocardiography Is Present in Patients with Shwachman-Diamond Syndrome Despite Normal Shortening Fraction. Pediatr Blood Cancer. 2015; 62:1228-31.
  168. Salloum R, Fox CE, Alvarez-Allende CR, Hammill AM, Dasgupta R, Dickie BH, Mobberley-Schuman P, Wentzel MS, Chute C, Kaul A, Patel M, Merrow AC, Gupta A, Whitworth JR, Adams DM. Response of Blue Rubber Bleb Nevus Syndrome to Sirolimus Treatment. Pediatr Blood Cancer. 2016; 63:1911-4.
  169. Salloum R, Hummel TR, Kumar SS, Dorris K, Li S, Lin T, Daryani VM, Stewart CF, Miles L, Poussaint TY, Stevenson C, Goldman S, Dhall G, Packer R, Fisher P, Pollack IF, Fouladi M, Boyett J, Drissi R. A Molecular Biology and Phase Ii Study of Imetelstat (Grn163l) in Children with Recurrent or Refractory Central Nervous System Malignancies: A Pediatric Brain Tumor Consortium Study. J Neurooncol. 2016; 129:443-51.
  170. Sampson LL, Davis AK, Grogg MW, Zheng Y. Mtor Disruption Causes Intestinal Epithelial Cell Defects and Intestinal Atrophy Postinjury in Mice. FASEB J. 2016; 30:1263-75.
  171. Satwani P, Ahn KW, Carreras J, Abdel-Azim H, Cairo MS, Cashen A, Chen AI, Cohen JB, Costa LJ, Dandoy C, Fenske TS, Freytes CO, Ganguly S, Gale RP, Ghosh N, Hertzberg MS, Hayashi RJ, Kamble RT, Kanate AS, Keating A, et al. A Prognostic Model Predicting Autologous Transplantation Outcomes in Children, Adolescents and Young Adults with Hodgkin Lymphoma. Bone Marrow Transplant. 2015; 50:1416-23.
  172. Segura-Cabrera A, Singh N, Komurov K. An Integrated Network Platform for Contextual Prioritization of Drugs and Pathways. Mol Biosyst. 2015; 11:2850-9.
  173. Serai S, Fleck R, Quinn C, Zhang B, Podberesky D. Retrospective Comparison of Gradient Recalled Echo R2*and Spin-Echo R2 Magnetic Resonance Analysis Methods for Estimating Liver Iron Content in Children and Adolescents. Pediatr Radiol. 2015; 45:1629-34.
  174. Sertorio M, Amarachintha S, Wilson A, Pang Q. Loss of Fancc Impairs Antibody-Secreting Cell Differentiation in Mice through Deregulating the Wnt Signaling Pathway. J Immunol. 2016; 196:2986-94.
  175. Sharp SE, Trout AT, Weiss BD, Gelfand MJ. Mibg in Neuroblastoma Diagnostic Imaging and Therapy. Radiographics. 2016; 36:258-78.
  176. Shaw B, Logan B, Kiefer D, Chitphakdithai P, Pedersen T, Abdel-Azim H, Abidi M, Akpek G, Diaz M, Artz A. Analysis of the Effect of Race, Socioeconomic Status, and Center Size on Unrelated National Marrow Donor Program Donor Outcomes: Donor Toxicities Are More Common at Low-Volume Bone Marrow Collection Centers. Biol Blood Marrow Transplant. 2015; 21:1830-38.
  177. Shi Y, Geller JI, Ma IT, Chavan RS, Masand PM, Towbin AJ, Chintagumpala M, Nuchtern JG, Tiao GM, Thompson PA, Vasudevan SA. Relapsed Hepatoblastoma Confined to the Lung Is Effectively Treated with Pulmonary Metastasectomy. J Pediatr Surg. 2016; 51:525-29.
  178. Smith E, Matrka M, Wells S. Hpv Virology: Cellular Targets of Hpv Oncogenes and Transformation. In: D Miller, M Stack, eds. Human Papillomavirus (Hpv)-Associated Oropharyngeal Cancer. New York: Springer; 2015:69-101.
  179. Sobecks RM, Wang T, Askar M, Gallagher MM, Haagenson M, Spellman S, Fernandez-Vina M, Malmberg KJ, Muller C, Battiwalla M, Gajewski J, Verneris MR, Ringden O, Marino S, Davies S, Dehn J, Bornhauser M, Inamoto Y, Woolfrey A, Shaw P, et al. Impact of Kir and Hla Genotypes on Outcomes after Reduced-Intensity Conditioning Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2015; 21:1589-96.
  180. Steed TC, Treiber JM, Patel K, Ramakrishnan V, Merk A, Smith AR, Carter BS, Dale AM, Chow LM, Chen CC. Differential Localization of Glioblastoma Subtype: Implications on Glioblastoma Pathogenesis. Oncotarget. 2016; 7:24899-907.
  181. Studebaker A, Bondra K, Seum S, Shen C, Phelps DA, Chronowski C, Leasure J, Smith PD, Kurmasheva RT, Mo X, Fouladi M, Houghton PJ. Inhibition of Mek Confers Hypersensitivity to X-Radiation in the Context of Braf Mutation in a Model of Childhood Astrocytoma. Pediatr Blood Cancer. 2015; 62:1768-74.
  182. Sturm D, Orr BA, Toprak UH, Hovestadt V, Jones DT, Capper D, Sill M, Buchhalter I, Northcott PA, Leis I, Ryzhova M, Koelsche C, Pfaff E, Allen SJ, Balasubramanian G, Worst BC, Pajtler KW, Brabetz S, Johann PD, Sahm F, et al. New Brain Tumor Entities Emerge from Molecular Classification of Cns-Pnets. Cell. 2016; 164:1060-72.
  183. Teusink A, Pinkard S, Davies S, Mueller M, Jodele S. Plerixafor Is Safe and Efficacious for Mobilization of Peripheral Blood Stem Cells in Pediatric Patients. Transfusion. 2016; 56:1402-05.
  184. Teusink A, Vinks A, Zhang K, Davies S, Fukuda T, Lane A, Nortman S, Kissell D, Dell S, Filipovich A, Mehta P. Genotype-Directed Dosing Leads to Optimized Voriconazole Levels in Pediatric Patients Receiving Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant. 2016; 22:482-6.
  185. Thowfeik FS, AbdulSalam SF, Wunderlich M, Wyder M, Greis KD, Kadekaro AL, Mulloy JC, Merino EJ. A Ros-Activatable Agent Elicits Homologous Recombination DNA Repair and Synergizes with Pathway Compounds. Chembiochem. 2015; 16:2513-21.
  186. Tiao G, Geller J, Timchenko N. Generation of Plc-Pdx Platforms for Pediatric Liver Cancer: A Critical Stage in the Development of Anti-Cancer Treatments. Hepatology (Baltimore, Md.). 2016; 64:1017-9.
  187. Trout A, Sharp S, Turpin B, Zhang B, Gelfand M. Optimizing the Interval between G-Csf Therapy and F-18 Fdg Pet Imaging in Children and Young Adults Receiving Chemotherapy for Sarcoma. Pediatric Radiol. 2015; 45:1001-06.
  188. Trout AT, Towbin AJ, Klingbeil L, Weiss BD, von Allmen D. Single and Multidimensional Measurements Underestimate Neuroblastoma Response to Therapy. Pediatr Blood Cancer. 2016.
  189. Tuttle T, Mierzwa M, Wells S, Fox S, Ben-Jonathan N. The Cyclic Gmp/Protein Kinase G Pathway as a Therapeutic Target in Head and Neck Squamous Cell Carcinoma. Cancer Letters. 2016; 370:279-85.
  190. Ullrich C, Rodday A, Bingen K, Kupst M, Patel S, Syrjala K, Harris L, Recklitis C, Schwartz L, Davies S. Parent Outlook: How Parents View the Road Ahead as They Embark on Hematopoietic Stem Cell Transplantation for Their Child. Biol Blood Marrow Transplant. 2016; 22:104-11.
  191. Unruh D, Srinivasan R, Benson T, Haigh S, Coyle D, Batra N, Keil R, Sturm R, Blanco V, Palascak M, Franco RS, Tong W, Chatterjee T, Hui DY, Davidson WS, Aronow BJ, Kalfa T, Manka D, Peairs A, Blomkalns A, et al. Red Blood Cell Dysfunction Induced by High-Fat Diet: Potential Implications for Obesity-Related Atherosclerosis. Circulation. 2015; 132:1898-908.
  192. Urbano-Ispizua A, Pavletic SZ, Flowers ME, Klein JP, Zhang MJ, Carreras J, Montoto S, Perales MA, Aljurf MD, Akpek G, Bredeson CN, Costa LJ, Dandoy C, Freytes CO, Fung HC, Gale RP, Gibson J, Hamadani M, Hayashi RJ, Inamoto Y, et al. The Impact of Graft-Versus-Host Disease on the Relapse Rate in Patients with Lymphoma Depends on the Histological Subtype and the Intensity of the Conditioning Regimen. Biol Blood Marrow Transplant. 2015; 21:1746-53.
  193. Varney M, Niederkorn M, Konno H, Matsumura T, Gohda J, Yoshida N, Akiyama T, Christie S, Fang J, Miller D. Loss of Tifab, a Del(5q) Mds Gene, Alters Hematopoiesis through Derepression of Toll-Like Receptor-Traf6 Signaling. J Exp Med. 2015; 212:1967-85.
  194. Varney ME, Melgar K, Niederkorn M, Smith MA, Barreyro L, Starczynowski DT. Deconstructing Innate Immune Signaling in Myelodysplastic Syndromes. Exp Hematol. 2015; 43:587-98.
  195. Wallace G, Jodele S, Howell J, Myers KC, Teusink A, Zhao X, Setchell K, Holtzapfel C, Lane A, Taggart C, Laskin BL, Davies SM. Vitamin D Deficiency and Survival in Children after Hematopoietic Stem Cell Transplant. Biol Blood Marrow Transplant. 2015; 21:1627-31.
  196. Wallace G, Myers K, Davies S, Teusink A, Jodele S. Rapid Rituximab Infusion Is Safe in Paediatric and Young Adult Patients with Non-Malignant Indications. Brit J Haematol. 2016; 173:480-81.
  197. Walter JE, Rosen LB, Csomos K, Rosenberg JM, Mathew D, Keszei M, Ujhazi B, Chen K, Lee YN, Tirosh I, Dobbs K, Al-Herz W, Cowan MJ, Puck J, Bleesing JJ, Grimley MS, Malech H, De Ravin SS, Gennery AR, Abraham RS, et al. Broad-Spectrum Antibodies against Self-Antigens and Cytokines in Rag Deficiency. J Clin Invest. 2015; 125:4135-48.
  198. Ware RE. Optimizing Hydroxyurea Therapy for Sickle Cell Anemia. Hematology Am Soc Hematol Educ Program. 2015; 2015:436-43.
  199. Ware RE, Davis BR, Schultz WH, Brown RC, Aygun B, Sarnaik S, Odame I, Fuh B, George A, Owen W, Luchtman-Jones L, Rogers ZR, Hilliard L, Gauger C, Piccone C, Lee MT, Kwiatkowski JL, Jackson S, Miller ST, Roberts C, et al. Hydroxycarbamide Versus Chronic Transfusion for Maintenance of Transcranial Doppler Flow Velocities in Children with Sickle Cell Anaemia-Tcd with Transfusions Changing to Hydroxyurea (Twitch): A Multicentre, Open-Label, Phase 3, Non-Inferiority Trial. Lancet. 2016; 387:661-70.
  200. Warren M, Turpin BK, Mark M, Smolarek TA, Li X. Undifferentiated Myxoid Lipoblastoma with Plag1-Has2 Fusion in an Infant; Morphologically Mimicking Primitive Myxoid Mesenchymal Tumor of Infancy (Pmmti)--Diagnostic Importance of Cytogenetic and Molecular Testing and Literature Review. Cancer Genet. 2016; 209:21-9.
  201. Watanabe M, Roth TL, Bauer SJ, Lane A, Romick-Rosendale LE. Feasibility Study of Nmr Based Serum Metabolomic Profiling to Animal Health Monitoring: A Case Study on Iron Storage Disease in Captive Sumatran Rhinoceros (Dicerorhinus Sumatrensis). PLoS One. 2016; 11:e0156318.
  202. Wong JC, Weinfurtner KM, Alzamora Mdel P, Kogan SC, Burgess MR, Zhang Y, Nakitandwe J, Ma J, Cheng J, Chen SC, Ho TT, Flach J, Reynaud D, Passegue E, Downing JR, Shannon K. Functional Evidence Implicating Chromosome 7q22 Haploinsufficiency in Myelodysplastic Syndrome Pathogenesis. Elife. 2015; 4.
  203. Wood JC, Cohen AR, Pressel SL, Aygun B, Imran H, Luchtman-Jones L, Thompson AA, Fuh B, Schultz WH, Davis BR, Ware RE, TWiTCH Investigators. Organ Iron Accumulation in Chronically Transfused Children with Sickle Cell Anaemia: Baseline Results from the Twitch Trial. Br J Haematol. 2016; 172:122-30.
  204. Wood JC, Pressel S, Rogers ZR, Odame I, Kwiatkowski JL, Lee MT, Owen WC, Cohen AR, St Pierre T, Heeney MM, Schultz WH, Davis BR, Ware RE, TWiTCH Investigators. Liver Iron Concentration Measurements by Mri in Chronically Transfused Children with Sickle Cell Anemia: Baseline Results from the Twitch Trial. Am J Hematol. 2015; 90:806-10.
  205. Wu J, Huang G, Ratner N. Runx1: A New Driver in Neurofibromagenesis. Oncoscience. 2015; 2:904-5.
  206. Wu J, Keng VW, Patmore DM, Kendall JJ, Patel AV, Jousma E, Jessen WJ, Choi K, Tschida BR, Silverstein KA, Fan D, Schwartz EB, Fuchs JR, Zou Y, Kim MO, Dombi E, Levy DE, Huang G, Cancelas JA, Stemmer-Rachamimov AO, et al. Insertional Mutagenesis Identifies a Stat3/Arid1b/Beta-Catenin Pathway Driving Neurofibroma Initiation. Cell Rep. 2016; 14:1979-90.
  207. Yan J, Wang Q, Zou K, Wang L, Schwartz EB, Fuchs JR, Zheng Z, Wu J. Inhibition of the Jak2/Stat3 Signaling Pathway Exerts a Therapeutic Effect on Osteosarcoma. Mol Med Rep. 2015; 12:498-502.
  208. Yang JQ, Kalim KW, Li Y, Zhang S, Hinge A, Filippi MD, Zheng Y, Guo F. Rhoa Orchestrates Glycolysis for Th2 Cell Differentiation and Allergic Airway Inflammation. J Allergy Clin Immunol. 2016; 137:231-45 e4.
  209. Yuasa M, Mignemi N, Nyman J, Duvall C, Schwartz H, Okawa A, Yoshii T, Bhattacharjee G, Zhao C, Bible J. Fibrinolysis Is Essential for Fracture Repair and Prevention of Heterotopic Ossification. J Clin Invest. 2015; 125:3117-31.
  210. Zhang L, He X, Liu L, Jiang M, Zhao C, Wang H, He D, Zheng T, Zhou X, Hassan A. Hdac3 Interaction with P300 Histone Acetyltransferase Regulates the Oligodendrocyte and Astrocyte Lineage Fate Switch. Dev Cell. 2016; 36:316-30.
  211. Zhang T, Wilson AF, Mahmood Ali A, Namekawa SH, Andreassen PR, Ruhikanta Meetei A, Pang Q. Loss of Faap20 Causes Hematopoietic Stem and Progenitor Cell Depletion in Mice under Genotoxic Stress. Stem Cells. 2015; 33:2320-30.
  212. Zhao C, Deng Y, Liu L, Yu K, Zhang L, Wang H, He X, Wang J, Lu C, Wu L. Dual Regulatory Switch through Interactions of Tcf7l2/Tcf4 with Stage-Specific Partners Propels Oligodendroglial Maturation. Nat Commun. 2016; 7.